Catalyst Pharmaceuticals (CPRX) Net Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,849.00 |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 254.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 254.00 |
| Dec 31, 2025 | -268.00 |
| Sep 30, 2025 | 147.00 |
| Jun 30, 2025 | 231.00 |
| Mar 31, 2025 | 1,649.00 |
| Dec 31, 2024 | 1,737.00 |
| Sep 30, 2024 | 6,406.00 |
| Jun 30, 2024 | -468.00 |
| Mar 31, 2024 | -1,101.00 |
| Dec 31, 2023 | -4,097.00 |
| Sep 30, 2023 | -6,970.00 |
| Jun 30, 2023 | -278.00 |
| Mar 31, 2023 | 391.00 |
| Dec 31, 2022 | 3,208.00 |
| Sep 30, 2022 | 1,101.00 |
| Jun 30, 2022 | 721.00 |
| Mar 31, 2022 | 536.00 |
| Dec 31, 2021 | -1,258.00 |
| Sep 30, 2021 | -11,910.00 |
| Jun 30, 2021 | 46.00 |
| Mar 31, 2021 | -1,041.00 |
| Dec 31, 2020 | 1,055.00 |
| Sep 30, 2020 | 10,372.00 |
| Jun 30, 2020 | -497.00 |
| Mar 31, 2020 | 4,096.00 |
| Dec 31, 2019 | 292,625.00 |